| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Investing - Don't Let Uncle Sam Take 80% Of Your IRA |
|
Top Articles - Investing - Don't Let Uncle Sam Take 80% Of Your IRA
Could you lose over 80% of your IRA to taxes when you die? Yes, unless you act before it’s too late. Read on to find out if this affects you and how you can minimize the effect of taxes on According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product your IRA. You’ve worked hard all your life and enjoyed a successful career. Along the way, you’ve sacrificed to put money into retirement programs, building a nest egg to provide for you a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nd your family the rest of your life. If you live just off the interest, you can leave a nice inheritance for your children. Unfortunately, Uncle Sam could take over 80% of it in taxes, le lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ving your children with much less than you expected. If you owe estate taxes at your death and haven’t planned properly, your children may be forced to tap into your retirement accounts. Th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe is could result in 35% being lost in income taxes on top of 48% being lost to estate taxes! There are two kinds of taxes that affect IRAs and other pre-tax accounts. The first is income ta d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro x. When money is withdrawn from these pre-tax accounts, ordinary income tax is paid on the full amount withdrawn. Withdraw $50,000 from your IRA, pay income taxes on $50,000. Since IRAs an ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc other retirement accounts have a beneficiary and, typically, are not subject to Probate, many people think they’re not subject to estate taxes. That’s wrong. The full value of these accoun easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ts is included in the value of your estate and may be subject to estate taxes. What’s worse, the value of your estate isn’t reduced by the income taxes due if you pull money out of these p nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically re-tax accounts. For instance, let’s say you have $1,000,000 in an IRA. Even though you would only have about $650,000 if you took it out and paid income taxes on it, the full $1,000,000 mi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ht be subject to estate taxes. Each of us has an estate tax exemption of $1,500,000 for 2004. If you’re married, that means you and your spouse should be able to pass on $3,000,000 before ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi worrying about estate taxes. But couples with smaller estates can still end up paying estate taxes. For instance, Bill and Sue are happily retired. Bill retired and rolled $1,000,000 into ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a a Traditional IRA. Sue also had an IRA worth $500,000. They owned a home and other real estate bringing the value of their estate to $2,500,000. Since his IRA would be his wife’s main sour dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e of income when he died, Bill named Sue as his primary beneficiary. He passes away and also leaves the rest of his share of the estate to Sue. There aren’t any estate taxes or income taxes cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin on transfers between spouses. The problem occurs when Sue dies. The value of the estate is $2,500,000. She can only pass $1,500,000 free of estate tax. The result is roughly $500,000 in e tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen state taxes must be paid 9 months after her death. Since the IRAs are the only source of readily available funds, the children withdraw money from Bill’s IRA. This means that almost $350,0 t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel 0 more is due in income taxes. How are they going to pay those additional income taxes? By taking more money out of the IRA. So the have to pay even more in income taxes! Ultimately, very ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust little of the IRA is left for the children. What can you do if your largest asset is an IRA and you face a similar situation? You can reduce the amount of estate taxes owed through the use y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products of special trust vehicles. Additionally, the portion of an IRA or estate that is not left to a surviving spouse counts toward the decedent spouses’ exemption, so leaving a portion of an I . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de A to a child instead of a spouse can reduce estate taxes. Life insurance can be used to provide the liquidity needed so that the children don’t have to tap the IRAs for funds to pay the es elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tate taxes. Consult with a qualified professional to properly take advantage of these complex strategies. But act now, because these strategies are only effective while you are still alive tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What Good is Viral if It Isn't Residual?
|